[HTML][HTML] Healthy axis: Towards an integrated view of the gut-brain health

F Boem, A Amedei - World Journal of Gastroenterology, 2019 - ncbi.nlm.nih.gov
Despite the lack of precise mechanisms of action, a growing number of studies suggests that
gut microbiota is involved in a great number of physiological functions of the human …

[HTML][HTML] Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions

MG Colombo, EI Musabaev, UY Ismailov… - World journal of …, 2019 - ncbi.nlm.nih.gov
Abstract Globally, 69.6 million individuals were infected with hepatitis C virus (HCV) infection
in 2016. Of the six major HCV genotypes (GT), the most predominant one is GT1, worldwide …

Quick and sensitive UPLC-ESI-MS/MS method for simultaneous estimation of sofosbuvir and its metabolite in human plasma

MH Semreen, HY Alniss, MK Mousa, HY Aboul-Enein - Molecules, 2019 - mdpi.com
A simple, fast and highly sensitive RP-UPLC-MS/MS method was developed and validated
for the simultaneous determination of sofosbuvir (SR) and its metabolite GS331007 in …

Pan-genotype pre-exposure prophylaxis (PrEP) allows transplantation of HCV-positive donor kidneys to negative transplant recipients

M Duerr, L Liefeldt, F Friedersdorff, M Choi… - Journal of Clinical …, 2020 - mdpi.com
Transplant candidates are facing incremental mortality risks on the waiting list. Here, we
report a novel strategy to expand the donor pool by including hepatitis C seropositive …

Evaluation of the pharmacokinetics and food intake effect of generic sofosbuvir in healthy Chinese subjects

X Li, Y Liu, B Xu, L Liu, Y Li, P Zhang… - International Journal of …, 2020 - search.proquest.com
Objective: Sofosbuvir is an NS5B nucleotide inhibitor that was approved for hepatitis C
treatment. Generic sofosbuvir has been produced to improve the affordability. The present …

Hepatitis C virus infection: Epidemiology in Egypt, Pathophysiology and DAAs-based therapy

HA Elbadawy, SA Wahdan… - … Sciences Ain Shams …, 2021 - journals.ekb.eg
Hepatitis C virus (HCV) was first identified in 1989. The situation in Egypt is really dire. The
prevalence of HCV genotype 4 (GT-4) is 14.7%. About 10% of the middle-aged population …

Terapi Kombinasi Sofosbuvir dan Daclatasvir Pada Pasien dengan Hepatitis C Kronik: Sebuah Tinjauan Literatur

SA Susilo, HO Saint, AH Saputra… - Health Information …, 2023 - myjurnal.poltekkes-kdi.ac.id
Abstrak Latar Belakang: Hepatitis C kronik merupakan penyakit hati yang disebabkan oleh
virus hepatitis c/HCV. World Health Organization/WHO melaporkan bahwa lebih dari 3 …

Therapie und Prophylaxe infektiöser Komplikationen bei nierentransplantierten Patienten

E Schrezenmeier - 2022 - refubium.fu-berlin.de
In der vorliegenden Arbeit haben wir uns mit den Folgen der sekundären Immundefizienz
bei nierentransplantierten Patienten beschäftigt. Diese hat sowohl Einfluss auf vom Spender …

Auswirkungen von immunologischen und nicht-immunologischen Faktoren auf den Verlauf einer Nierentransplantation

F Halleck - 2021 - refubium.fu-berlin.de
Angesichts des ausgeprägten Organspendermangels sollte aktuell mehr denn je das
bestmögliche Ergebnis für jede individuelle Transplantation erreicht werden. Ein vorzeitiges …

Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions

I Zaytsev, M Colombo, E Musabaev, O Golubovska… - 2019 - ir.librarynmu.com
Globally, 69.6 million individuals were infected with hepatitis C virus (HCV) infection in 2016.
Of the six major HCV genotypes (GT), the most predominant one is GT1, worldwide. The …